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1.0 INTRODUCTION 
Ultrasound is the primary imaging modality in obstetrics over the last three 
decades. The advent of high-resolution transvaginal ultrasound (TVS) has 
revolutionized our understanding of the pathophysiology and the management of 
early pregnancy failure. Knowledge of the ultrasound appearances of normal early 
pregnancy development and a good understanding of its pitfalls are essential for 
the diagnosis and management of early pregnancy failure. 
Ultrasound imaging has rapidly replaced all other techniques used to study 
normal human development in the first trimester, and ultrasound features of the 
early gestational sac have corroborated anatomical studies showing that the first 
structures to appear are the coelomic cavity and the secondary yolk sac. No single 
ultrasound measurement of the different anatomical features in the first trimester 
has been shown to have a high predictive value for determining early pregnancy 
outcome. This prospective correlational study is conducted to assess the correlation 
of first trimester pregnancy outcome using yolk sac measurements and embryonic 
heart rate. 
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2.0. AIMS & OBJECTIVES 
A great challenge exists in predicting the first trimester outcome using 
Ultrasound examination till date. I have chosen this topic as the subject of my 
study because prediction of first trimester outcome is important for expectant 
management and counsel the patient for her pregnancy outcome which is the 
pivotal task in the era of assisted fertility.  
• This study is conducted to assess the correlation of patient’s first trimester 
outcome (Normal  continuation  of  pregnancy  / Miscarriage) with the  yolk 
sac size and the embryonic heart rate at 6‐12 wks gestation.  
• To  evaluate  the  association  of  patient’s  age,  consanguinity,  menstrual 
history, parity and medical illness with first trimester outcome. 
• To evaluate the other sonographic parameters like Crown Rump Length and 
mean sac diameter with first trimester outcome. 
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3.0. REVIEW OF LITERATURE 
[1],[2],[3] 
 
“Everything has been thought of before but the problem is to think of it again” 
  
                                                                                                     -GOETHE 
Ultrasound is defined as the sound above the range of human hearing that  
is above the frequency  of 20,000 Hertz .Normal human hearing frequency range is 
between 20 Hz – 20,000 Hz . Bats, dolphins and dogs can hear ultrasound. 
 
3.1. HISTORICAL BACKGROUND 
History is bunk – but we can learn from it, this is a famous quote of Henry 
Ford. Ultrasound was first demonstrated by Spellannizine in 1794 on bats. Langria 
of France used it for detection and destruction of submarines during First World 
War 1915. It was named SONAR – Sound, Navigation and ranging. It was used to 
detect flaw in metals and metallic structures like bridges, beams, etc.  The first 
medical use was done by Dussik in 1930 for visualization of cerebral ventricles. 
But his technique was very crude. 
Professor Ian Donald of Glasgow (1960) reintroduced with much 
modifications and he is called as the “Father of Modern ultrasound”. He 
improved the contact between US source and the patient’s body by placing the 
patient in water and finally by smearing the skin with oil or jelly. He insisted on 
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“full bladder” technique because ultrasound traverses best through fluid medium. 
The fetus stands as an ideal subject for ultrasound investigation as it remains 
surrounded by water all time. 
Ultrasonography as a technique for determining the foetal gestational age 
was introduced in the nineteen fifties. In a surprisingly short span of time, 
development and improvisations in newer technology and research methodology 
has led to a mind-boggling improvement in assessment of foetal gestation using 
various parameters. 
3.2. BASIC PHYSICS OF ULTRASOUND 
Ultrasound uses sound waves between 1 and 30 MHZ. Most obstetric and 
gynecological applications employ sonic frequencies between 2 and 5 MHZ. the 
higher the frequency, greater is the attenuation and lesser is the penetration. 
Mineral oil or gel is applied to the skin to abolish the air tissue interphase. 
Similarly gas in the intestine blocks the penetration. 
3.2.1. Production of ultrasound 
The property of piezo electricity is the ability of certain crystals to convert 
one form of energy into another and vice versa. 
Electrical energy (change of shape)                   Mechanical Energy (Mechanical 
vibration)               sound energy  
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The natural crystal possessing piezo electricity is quartz, which is now 
replaced almost entirely by synthetic ceramic crystals such as barium titenate and 
lead zirconate, titanate. In medical applications, these crystals are cut into thin 
wafers and are mounted on a transducer probe. 
3.2.2. Ultra sonic technique 
1. Pulsed echo technique - provide the location of anatomic structure by 
measuring the transit time for sound to reach the structure and return to the 
ultrasonic detection. This is the technique applied in equipment used in this 
study. 
2. Doppler technique: frequency of returning echoes are analyzed to determine the 
velocity of moving structure. 
3. Transmission technique: sound completely traversing the body is analyzed for 
transit time, intensity, phase shift etc. 
3.2.3. Pulsed echo technique Principle 
The principle of pulsed echo technique is detection of all returning echoes of 
short ultra sonic pulses transmitted. The amplitude of each echo depends on the 
orientation of the reflecting surface and the differences in acoustic impedance of 
the tissues at the interface. Echoes detected by the transducer are displayed on an 
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oscilloscope in either A mode, B mode or B scan presentations. The same 
transducer element is used for both transmitting and receiving. 
3.2.4. Types of images 
3.2.4.a. A Mode: Amplitude modulation echoes are displayed as vertical 
deflections from the base line with the height of deflection proportional to the 
strength of the detected echo. 
3.2.4.b. B Mode :    In this mode an object is scanned in two axes- longitudinal 
and transverse. A 2D image of the object is obtained. The image here is made up of 
bright dots of light. Hence the name brightness mode. 
3.2.4.c. M Mode: Motion display consists of B mode in which the baseline is 
continuously raised. A timed photographic exposure records the movements of 
anatomic structures. 
3.2.5. B Scan: It provides 2 –D cross sectional visualization. B scan is obtained by 
moving the transducer over the surface of the body and displaying the echoes on 
the B mode. The transducer is attached to an articulated arm which provides the 
ultrasound system information on transducer position and orientation. The image in 
B scan is static. Contact scanning is used in obstetric scans. An acoustic coupling 
agent like gel is applied to the skin surface and the transducer is manually moved 
across the skin. 
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3.2.5.a. Real time B scan: 
It is the detection and display of motion as it occurs. Real time systems 
provide a cinematic view of the area being evaluated by displaying a rapid series of 
images sequentially. 
3.2.5.b. Gray scale 
It is a scale for quantification of echo signals to help in the interpretation of 
an US image. A black and white US image is made up of ‘dot of light’(pixcels) the 
brightness proportional to the strength of the returning echo. The gray areas of 
varying intensity which are seen in between the white dots of light signify 
sonolucent areas.  
Ultrasound pictures illustrating the measurements of GSD and CRL. 
 
15 
 
 
3.3. PHYSIOLOGY OF HUMAN PLACENTATION 
3.3.1. The in-vivo anatomy of early pregnancy 
 
       The preparation period for the implantation starts shortly after fertilization, 
during  preimplantation period, through both local and systemic signaling. 
Substances from embryo deposited freely in the uterine lumen are involved in 
signaling to maternal host and in preparing the site to impending implantation 
(decidualization). After the blastocyst reaches the uterine cavity, some important 
changes occur: 
1. The zona pellucida is enzymatically loosened by means of a trypsin-like 
enzyme, secreted by the trophoblast; 
2. The blastocyst “hatches” out; 
3. The blastocyst attaches by the area above the inner cell mass (embryonic pole) 
to the endometrial surface epithelia. 
4. The next stage of implantation (7th day of development, Carnegie stage 5a) is an 
active penetration (“invasion”) of the uterine epithe-lium. By that time the 
trophoblast undergoes its differentiation into inner cellular layer—cytotrophoblast, 
and outer multinucleated syncytiotrophoblast, which is at the embryonic pole 
highly invasive. 
16 
 
Lacunar or Previllous Stage 
By 9th day of development (Carnegie stage 5b) syncytiotrophoblast progresses and 
invades endometrial stroma. Vacuoles appear in the syncytiotrophoblast at the 
embryonic pole of the blastocyst. A few vacuoles coalesce and form 
intercommunicating cavities. Their fluid-filled spaces develop in the lacunae. 
Between 10th and 13th days trophoblast pene-trates deeper into endometrial 
stroma and erodes the adjacent maternal capillaries. 
Bilaminar Embryonic Disc 
During the implantation period and differentiation of the trophoblast, the 
inner cell mass or embryo-blast rearrange into two epithelial layers: the epiblast or 
primitive ectoderm and the hypoblast or primitive endoderm. Epiblast and 
hypoblast form bilaminar embryonic disc. Approximately 7 days after fertilization, 
amniotic cavity appears. Meanwhile the hypoblast cells migrate along the inner 
side of the wall of the blastocoele cavity forming the extraembryonic endoderm 
called primary yolk sac. Starting about 12 days after fertilization the 
extraembryonic mesoderm appears. The extraembryonic mesoderm supports the 
epithelium of yolk sac and amnion as well as the chorionic villi, which arise from 
the trophoblast. This mesoderm has an important role in differentiation of the first 
primitive blood vessels. 
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Ultrasound imaging has shown that the extrachorionic cavity is the largest 
anatomical space inside the gestational sac between 5 and 9 weeks of gestation. 
The development of the ECC is intimately linked with that of the secondary yolk 
sac (SYS), for which it provides a stable environment. The SYS degenerates 
spontaneously at around 9–10 weeks, by which time the fetal metanephros has 
started to function and produce urine which is passed into the amniotic cavity. 
Subsequently, with the accumulation of this fluid the amniotic membrane moves 
towards the fetal plate of the placenta, and the ECC will almost entirely disappear 
by 12–13 weeks of gestation. The development of TVS-guided sampling 
procedures has allowed direct access to the embryonic fluid cavities. Protein 
electrophoresis has shown that the celomic fluid results from an ultrafiltrate of 
maternal serum with the addition of specific placental and SYS bioproducts. 
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 The higher concentrations of human chorionic gonadotropin (hCG), estradiol, 
estriol and progesterone in the celomic fluid than in maternal serum strongly 
suggest the presence of a direct pathway between the trophoblast and the ECC. 
Morphologically, this may be via the villous stromal channels and the loose 
mesenchymal tissue of the chorionic plate. These findings suggest that the ECC is 
a physiological liquid extension of the early placenta, and an important interface in 
fetal nutritional pathways. 
 
3.3.2.The intervillous circulation 
Traditionally, it has been assumed that the maternal intraplacental 
circulation is established soon after implantation, making the human placenta 
hemochorial throughout pregnancy. However, evidence from morphological 
studies, hysteroscopy, perfusion of hysterectomy specimens with pregnancy in situ, 
and Doppler/ultrasound studies of the early placenta indicates that significant flow 
does not occur until the end of the first trimester, at approximately 10 weeks of 
gestation. This change in blood flow is intimately linked to the extravillous 
trophoblast migration, for during early pregnancy aggregates of these cells 
effectively plug the mouths of the spiral arteries, creating a trophoblastic shell 
between the tip of the spiral arteries and the placental intervillous space.  At around 
the tenth week these plugs start to dissipate, establishing free communications 
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between the spiral arteries and the placenta. The fact that greater trophoblast 
invasion occurs in the central region of the placental bed suggests that the plugs are 
more extensive and complete in this region. It might be predicted, therefore, that 
dissipation of the plugs will occur first at the periphery of the placenta, and our 
recent Doppler studies have confirmed that this is the case in the majority of 
normal pregnancies. Thus, if these plugs prevent a continuous flow of maternal 
blood into the intervillous space during normal early pregnancy, then the human 
placenta cannot be truly hemochorial until the end of the first trimester. As judged 
by adult tissue criteria, the human fetus develops in a low oxygen environment. 
The trophoblastic cells are extremely sensitive to oxidative stress because of their 
extensive cell divisions and the concomitant exposure of their DNA. There are 
major changes in placental oxygenation and antioxidant enzymes expression at the 
transition between the first and second trimesters of pregnancy. This physiological 
burst of oxidative stress may play an important physiological role in triggering 
normal placental differentiation. The presence of a gradient between the maternal 
and fetal tissues is essential as it influences cytotrophoblast proliferation and 
differentiation along the invasive pathway and promotes villous vasculogenesis. As 
pregnancy advances between 7 and 16 weeks there is a progressive but 
independent increase in decidual pO2, which is most probably due to the increase 
in maternal uterine blood flow volume. As described above, in most normal first-
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trimester pregnancies early intervillous flow (i.e. at 8–9 weeks of gestation) is 
restricted to the peripheral regions of the placenta. This regional physiological 
oxidative stress is probably the trigger for the formation of the placental 
membranes. In threatened miscarriage, the maternal symptoms result from a 
subchorionic hemorrhage or bleed in this peripheral area. In missed miscarriages, 
however, flow is most common in central regions or throughout the 
placenta. These data suggest that the normal establishment of a continuous 
intervillous circulation is an incremental phenomenon starting in the periphery and 
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expanding progressively to the rest of the placenta thereafter. This concept is 
supported by the immunohistochemical and morphological evidence of 
temporospacial differences in the degree of trophoblastic stress in normal and 
abnormal early pregnancies. Overall, these ultrasound, anatomical and 
physiological data provide direct evidence that the architecture of the human first- 
trimester gestational sac limits fetal exposure to O2, keeping its chemical activity 
to what is strictly necessary for its development and to minimize the damage 
caused by oxygen free radicals. 
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3.4. ULTRASOUND AND THE PATHOPHYSIOLOGY OF EARLY 
PREGNANCY FAILURE 
Human placentation is more complex than that of other mammalian species, 
including the higher primates. Abnormalities of placentation are associated with 
diseases that are almost unique to the human species, such as preeclampsia or 
hydatidiform mole, or rare in other species, such as miscarriage. Abnormally high 
or rapidly fluctuating concentrations of oxygen have a harmful effect on tissue and 
in particular on trophoblastic tissue. There is increasing evidence to indicate that 
failure of placentation is associated with an imbalance in reactive oxygen species 
(ROS), which will further affect placental development and function and may 
subsequently have an influence on both the fetus and its mother.  
Maternal metabolic disorders, for example diabetes, which are associated 
with an increased production of ROS are also known to be associated with a higher 
incidence of miscarriage and fetal structural defects. Furthermore, the 
teratogenicity of drugs such as thalidomide has been shown to involve ROS 
mediated oxidative damage, indicating that the human fetus can be irreversibly 
damaged by oxidative stress. These findings suggest that fetal development is 
highly sensitive to disruption by ROS, and hence maintaining a low O2 
environment inside the human uterus during early pregnancy may confer 
protection. 
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3.4.1. Implantation 
There is increasing evidence showing an association between miscarriage 
and an anomaly of one of the enzymes involved in the metabolism of ROS. These 
findings suggest that an early pregnancy failure can be due to a primary defect of 
placentation involving a genetic anomaly of the enzymes or cofactor involved in 
the metabolism of oxygen. Our recent data on the role of uterine glands in early 
fetal nutrition suggest that insufficient decidualization could also have an impact 
on placentation. These glands remain active until at least the tenth week of 
pregnancy, and their secretions are delivered freely into the placental intervillous 
space.  
An endometrial thickness of 8-14 mm or more is considered to be favorable 
for embryo implantation. Both adequate endometrial thickness and vascularization 
are needed for implantation, and women with a good endometrial thickness on 
ultrasound but a poor intra-endometrial blood flow tend to have a poor 
reproductive outcome. It has been suggested that uterine artery impedance plays 
an important role in endometrial receptivity prior to implantation. Delay in the 
normal lowering of uterine arterial resistance may result in impaired endometrial 
function and recurrent miscarriage. Use of Doppler assessment of the uterine 
vasculature may be useful in determining optimal endometrial receptiveness in 
assisted reproduction cycles. 
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3.4.2. Miscarriage and placental blood flow 
There is substantial anatomical evidence that in the majority of cases, the 
most common complications of pregnancy (i.e. spontaneous miscarriage and 
preeclampsia) stem from a defect in early trophoblast invasion and a failure to 
convert the spiral arteries into low-resistance channels. In about two thirds of early 
pregnancy failures there is anatomical evidence of defective placentation, which is 
mainly characterized by a thinner and fragmented trophoblast shell, and reduced 
cytotrophoblast invasion of the lumen at the tips of the spiral arteries. This is 
associated with premature onset of the maternal circulation throughout the placenta 
in most cases of miscarriage. These defects are similar in euploid and most 
aneuploid miscarriages, but are more pronounced in triploid partial moles. In 
complete hydatidiform mole the extravillous trophoblast invasion into the decidua 
and superficial myometrium is almost entirely absent. The syncytiotrophoblast 
degeneration/regeneration is probably most extensive in cases of missed 
miscarriage, in which maternal blood flow is premature and widespread.  
The excessive entry of maternal blood into the intervillous space has a direct 
mechanical effect on the villous tissue and an indirect oxidative stress effect, which 
contributes to cellular dysfunction and/or damage. Complete loss of 
syncytiotrophoblast function through oxidative stress would, of course, lead to a 
precipitate fall in hCG concentration, and hence to early pregnancy failure. 
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Oxidative stress is well known to initiate the caspase cascade leading to cell death 
in other systems. Generation of ROS in large quantities, such as in maternal 
diabetes, in the first-trimester placenta, which has limited antioxidant defenses, 
may cause DNA damage and oxidation of proteins and lipid resulting in extensive 
cell death. Apoptosis has been found to be intensified in cases of miscarriage and 
concentrations of lipid peroxides increase in the decidua of women undergoing 
early pregnancy loss. The celomic fluid in missed miscarriages has also been 
investigated but has only provided limited information on the mechanisms of early 
pregnancy failure.  
The fluid collected in anembryonic pregnancies is of exocelomic origin and 
its biochemical characteristics reflect a failure of most placental biological 
mechanisms such as metabolic function, transport function and endocrine activity. 
These findings support the concept that embryonic and placental development are 
closely related in the first trimester of human pregnancy, placental biological 
functions persisting only for a limited period of time after embryonic demise. 
Normal or high maternal serum alpha-fetoprotein (AFP) levels and AFP molecules 
predominantly of yolk sac origin in the celomic fluid of pregnancies with an empty 
gestational sac on ultrasonography provide further evidence that the most likely 
explanation for this feature is the early death of the embryo with persistence of the 
placental tissue. The uteroplacental circulation is a dynamic model in which the 
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magnitude of blood flow through a single vessel may vary significantly, therefore 
the evaluation of blood flow in single uteroplacental vessels is often difficult to 
interpret and is of limited value in understanding the pathophysiology of placental-
related disorders of pregnancy. Recent work has suggested that although Doppler 
sonography in early pregnancy has not been found to be a useful screening tool for 
placental-related disorders such as pre-eclampsia and growth restriction, there may 
be a role for its use towards the end of the first trimester. These findings clearly 
need further investigation, as the discovery of a non-invasive screening test for 
disorders of placental function early in pregnancy remains elusive. 
3.4.3. Threatened miscarriage 
Threatened miscarriage occurs in 15–20% of viable pregnancies and is one 
of the commonest gynaecological emergencies. In the past, much emphasis has 
been placed on the volume of an intrauterine hematoma (IUH) or on the presence 
of vaginal bleeding but not on the location of the hemorrhage. It is likely if the 
bleeding occurs at the level of the definitive placenta (under the cord insertion) it 
may result in placental separation and subsequent abortion. Conversely, an IUH 
that only detaches the membrane a distance away from the cord insertion can 
probably reach a significant volume before it affects normal pregnancy 
development by a direct volume pressure effect. The presence of a hematoma may 
also be associated with a chronic inflammatory reaction in the decidua, resulting in 
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persistent myometrial activity and expulsion of the pregnancy. As mentioned 
previously, in about two-thirds of early pregnancy failures there is defective 
placentation which is mainly characterized by a thinner and fragmented trophoblast 
shell, and reduced cytotrophoblast invasion of the lumen at the tips of the 
spiral arteries. The development of a hematoma may be the first sign of an 
incomplete placentation and be associated with acute oxidative stress, which may 
impair subsequent placental and membrane development. A delicate balance 
is probably achieved between the production of free radicals and protective 
antioxidant activity in early pregnancy. Any change in this equilibrium, resulting in 
an increase in free radical formation, such as a premature influx of oxygenated 
maternal blood, the presence of substances which form free radicals or a reduction 
in local antioxidant levels, may well result in an impairment in placentation, and 
subsequent pregnancy complications, from miscarriage at one end of the spectrum 
and preterm premature rupture of membranes (PPROM)  and preeclampsia 
at the other. There is already mounting evidence of a role for free radical damage 
in PPROM and preeclampsia, however, its role in miscarriage is only recently 
emerging. The excessive entry of maternal blood inside the membranes, if located 
near the placenta, may have a direct mechanical effect on the villous tissue, and 
an indirect oxidative stress effect which contributes to cellular dysfunction and/or 
damage. 
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3.5. ULTRASOUND AND THE DIAGNOSIS OF MISCARRIAGE 
The use of TVS has clearly revolutionized the management of early 
pregnancy problems. The development of highly sensitive urinary hCG assays and 
greater awareness of early pregnancy ultrasound amongst health care professionals 
and women alike has resulted in ever earlier presentation. This has led to an 
increase in the number of inconclusive scans and as a result an increase in the 
requirement for repeat assessments to determine both pregnancy location and 
viability. Knowledge of the typical ultrasound appearances of normal early 
pregnancy development and a good understanding of its pitfalls is essential for the 
diagnosis and management of early pregnancy failure. Use of appropriate 
terminology to describe clinical and ultrasound findings in early pregnancy failure 
is also essential, and the use of obsolete terms such as blighted ovum, anembryonic 
sac and trophoblastic bleeding should be abandoned. Such descriptions are of 
limited clinical usefulness and have no histopathological correlates and have 
therefore been replaced by more ultrasound-based terminology. 
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3.5.1. Gestational sac 
 
      The inner cell mass: A group of blastomeres that give rise to the embryo. 
On day 20 of the cycle the blastocyst attaches to the endometrium usually on the 
site of the inner cell mass. 
The trophoblast starts to proliferate rapidly and differentiate into two layers: 
• Cytotrophoblast: Inner layer of cells. 
• Syncytiotrophoblast: Outer layer of cells. 
The Syncytiotrophoblast extends through the endometrium and invades the 
endometrial connective tissue. By day 21 of the menstrual cycle the blastocyst is 
superficially implanted, and by day 23 it is completely implanted into the 
endometrium. Isolated cavities called lacunae appear in the Syncytiotrophoblast, 
the uterine vessels erode and come in contact with these lacunae to build the 
beginning of the uteroplacental circulation. The Syncytiotrophoblast begins to 
produce a hormone, the human chorionic gonadotrophin (hCG), which enters the 
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aforementioned lacunae to the maternal blood. As the conceptus implants, cells of 
the endometrium swell because of accumulation of glycogen and lipids. These 
changes in the endometrium are known as the decidual reaction.  
ULTRASOUND FINDINGS 
By the time the blastocyst is implanted in the endometrium, the conceptus 
measures 0.1 mm and cannot be detected by the available ultrasound equipment. 
More reliable evidence of the presence of pregnancy is the demonstration of 
trophoblastic flow with Transvaginal Color Flow Doppler (TVCFD),7,8 which is 
characterized by a high-velocity, low-impedance signal. It has been suggested that 
the increased blood flow velocity in the endometrium is due to the invasion of the 
decidua by the chorionic villi.10 The peak flow velocity in a normal pregnancy 
ranged from 8 to 30 cm/sec before TVS visualization of the intradecidual sac. 
      The deciduo-placental interface and the ECC are the first sonographic evidence 
of a pregnancy that can be visualized with TVS from around 4.4–4.6 menstrual 
weeks (32–34 days) when they reach together a size of 2–4 mm. In normal 
intrauterine pregnancies between the fifth and sixth weeks, the gestational sac 
grows at a rate of approximately 1 mm/day in mean diameter. Gestational sac 
growth has been documented on serial ultrasound examinations to be slower in 
women who subsequently miscarry; however, it has long been recognized that 
there is wide scatter in gestational sac volume measurements in ‘normal’ early 
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pregnancy. Once a gestational sac has been documented on ultrasound, subsequent 
loss of viability in the embryonic period remains around 11%. A smaller than 
expected gestational sac can be a predictor of poor pregnancy outcome, 
both alone and in combination with other parameters, even in the presence of 
embryonic cardiac activity. In very early pregnancy, there appears to be no 
difference in gestational sac diameter (GSD) when compared with pregnancy 
outcome69, the difference only becoming apparent from 5 weeks onwards. 
Unfortunately, the predictive value of a smaller than expected GSD in isolation 
is variable and highly dependent upon other presenting factors. Interpretation of 
pregnancy outcome data for any variable in early pregnancy is hampered by 
significant differences in study design and entry criteria.  
Gestational sacs are usually round, but as they grow they frequently become 
elliptic and they may get irregular in shape as a result of: 
• Uterine myoma 
• Uterine contraction 
• Bleeding surrounding the implantation site 
• Distended maternal bladder 
 
Table demonstrates how published study populations vary, including low-
risk, asymptomatic women, women with threatened miscarriage and women 
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undergoing assisted conception techniques. Demographic data are often not 
accounted for and clearly these data should not be directly compared, and findings 
should not be applied to all populations. Studies involving women undergoing 
assisted conception are likely to be most accurate in terms of precise dating of the 
pregnancy, particularly as miscarriage rates for such pregnancies are now believed 
to be comparable to the fertile population. Overall, multivariate analyses appear to 
provide the most sensitive predictors of pregnancy outcome and GSD features 
strongly in combination with one or two other parameters in all of these models. 
Small gestation sac size can also be associated with chromosomal abnormality. 
Triploidy and trisomy 16 are more often associated with a small chorionic sac 
before 9 weeks’ gestation than other chromosomal abnormalities. 
 
3.5.2. Crown–rump length 
The now classical study by Robinson and Fleming on crown–rump length (CRL) is 
still the main reference for the assessment of gestational age in early pregnancy. 
Because TVS provides superior resolution and more accurate identification of the 
embryonic structures than abdominal ultrasound, new charts have been developed 
for the period of gestation before 7 weeks. In a normal pregnancy the amnion may 
be visualized when the crown-rump length is 5 mm and is routinely detectable 
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when the CRL is 7 mm or more. From this age onwards the amniotic sac diameter 
as well as the CRL increase by 1 mm per day. 
       The risk of early pregnancy loss relation to CRL values 
CRL (mm) Possibility for pregnancy loss (%) 
<5 8 
6–10 3–4 
>10 below 1 
If an embryo has developed up to 5 mm in length, subsequent loss of 
viability occurs in 7.2% of cases. Loss rates drop to 3.3% for embryos of 6–10 mm 
and to 0.5% for embryos over 10 mm.  
There is conflicting evidence for an association between early growth 
restriction, as defined by a deficit between the CRL and that predicted by the last 
menstrual period, and karyotypic abnormalities. A smaller than expected CRL has, 
however, been associated with subsequent miscarriage. Mean GSD:CRL ratios 
have also been used to predict pregnancy outcome with varying degrees of 
accuracy. Unfortunately this technique, as is the case for GSD measurements, is of 
limited clinical usefulness in isolation. 
3.5.3. Secondary yolk sac 
The first structure to be seen inside the gestational sac, before the embryo 
itself, is the SYS which can be observed from the beginning of the fifth week of 
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gestation or when the gestational sac reaches 10 mm in diameter. The SYS 
diameter increases slightly between 6 and 10 weeks’ gestation and then decreases. 
The comparison of ultrasound features with morphological findings indicates that 
when the SYS reaches its maximum sonographic size, it already shows important 
degenerative changes. This suggests that the disappearance of the SYS in normal 
pregnancies is a spontaneous event in embryonic development rather than the 
result of mechanical compression by the expanding amniotic cavity. The predictive 
value of SYS measurements in determining the outcome of an early pregnancy is 
limited, most pregnancies which miscarry during the third month of pregnancy 
have normal SYS measurements at their initial scan before 8 weeks of gestation. It 
is usually the yolk sac that is found to persist inside the gestational sac after 
embryonic demise. This would suggest that variations in SYS size and sonographic 
appearance in most abnormal pregnancies are probably the consequence of poor 
embryonic development or embryonic death rather than being the primary cause of 
early pregnancy failure. 
3.5.4. Fetal heart pulsation 
Extensive research has been published examining the predictive value of 
fetal heart activity on pregnancy outcome. Studies can be broadly divided into 
those examining fetal loss after confirmed fetal cardiac activity, and those 
examining fetal heart rate (FHR) in relation to outcome. Fetal heart activity is the 
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earliest proof of a viable pregnancy and it has been documented in utero by TVS as 
early as 36 days’ menstrual age, approximately at the time when the heart tube 
starts to beat. Theoretically, cardiac activity should always be evident when the 
embryo is over 6 mm. However, in around 5–10% of embryos between 2 and 4 
mm it cannot be demonstrated, although the corresponding pregnancies will have a 
normal outcome. From 5 to 9 weeks of gestation there is a rapid increase in the 
mean heart rate from 110 to 175 beats per minutes (bpm). The heart rate then 
gradually decreases to around 160–170 bpm. Abnormal developmental pattern of 
FHR and/or bradycardia has been associated with subsequent miscarriage. In 
particular, a slow FHR at 6–8 weeks appears to be associated with subsequent fetal 
demise. 
 A single observation of an abnormally slow heart rate does not necessarily 
indicate subsequent embryonic death, but a continuous decline of embryonic 
heart activity along with irregularity is inevitably associated with miscarriage In 
women with recurrent spontaneous miscarriage (defined a three or more 
consecutive losses in the first trimester) there has been much debate regarding 
whether there is an increased likelihood that fetal heart pulsations will be seen on 
TVS when compared with idiopathic spontaneous miscarriages, suggesting a 
different pathophysiology leading to pregnancy loss in these cases. Evidence 
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would suggest, however, that fetal loss patterns are no different between these 
groups. 
3.5.5. Other sonographic features 
The shape of the gestational sac, the echogenicity of the placenta, the 
thickness of the trophoblast and the presence of an intrauterine hematoma have all 
been proposed as sonographic markers associated with early spontaneous 
miscarriage. Many of these studies, however, often highlight problems with 
experimental design rather than providing unequivocal answers. IUHs are crescent-
shaped, echo-free areas between the chorionic membrane and the myometrium. 
Understanding of the resolution of these hematomas and the prognostic relevance 
of this ultrasound finding are limited. Many authors have previously focused on an 
association between the size of the hematoma and subsequent obstetric 
complications. Overall, the presence of an IUH has been associated with a 4–33% 
rate of miscarriage depending on the gestational age at which the complication was 
described.  Conversely, threatened miscarriage symptoms at 7–12 weeks, even in 
the presence of detectable fetal cardiac activity, is not only associated with a 5–
10% miscarriage rate before 14 weeks of gestation but also with adverse pregnancy 
outcome at later gestations. In particular, women with bleeding in the second half 
of the first trimester are at higher risk of PPROM and preterm labor. These risks 
are independent of the presence or absence of an IUH on the initial ultrasound 
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examination and would suggest that threatened miscarriage in the first trimester is 
a risk factor for adverse pregnancy outcome regardless of the ultrasound findings. 
3.5.6. Color Doppler imaging 
      The ability of transvaginal color Doppler imaging to detect FVWs from small 
vessels such as the terminal part of the uteroplacental circulation has given rise to 
much enthusiasm from clinicians interested in predicting early and late pregnancy 
complications related to an abnormal placentation. Overall, the predictive value of 
Doppler measurements of resistance to blood flow in early pregnancy is limited.             
All Doppler studies in the first trimester have failed to demonstrate abnormal blood 
flow indices in the uteroplacental circulation of pregnancies that subsequently 
ended in miscarriage. Histological assessment of decidual endovascular trophoblast 
invasion in first-trimester pregnancies about to undergo therapeutic evacuation, 
with low- and high resistance umbilical artery Doppler measurements, has shown 
that although the proportion of vessels invaded is increased in women with low-
resistance Dopplers, invasion is normal in both groups. A comparison of uterine 
and intraplacental blood FVWs with pathological features in missed miscarriages 
and normal pregnancies has shown that in the former the mean pulsatility index is 
higher and the intervillous flow premature and increased. These findings are 
associated with abnormal placentation and dislocation of the trophoblastic shell 
and are only found when the process of miscarriage is established and irreversible. 
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Studies did not show any difference in terms of RI and PI of the intervillous 
arterial blood flow between women with missed abortion and those with normally 
developing pregnancy. Being aware that chromosomal abnormalities are one of the 
most important factors for spontaneous abortion occurring uterine artery does not 
have any clinical role in the management of early pregnancies complicated by 
uterine bleeding. Analyzing intervillous circulation as one of the first 
ultrasonographic signs of the pregnancy, studies demonstrated lower vascular 
resistance of the arterial-like signals in the patients with blighted ovum when 
compared with the normal pregnancies. 
 
3.5.7. Three-dimensional ultrasound 
The emergence of three-dimensional (3D) ultrasound in obstetrics provided 
an opportunity to revisit previously abandoned or disregarded obstetric ultrasound 
parameters, particularly in early pregnancy. 3D assessment of gestational sac 
volume in the first trimester has been found to be a sensitive indicator of 
pregnancy outcome, with a smaller than expected gestational sac volume being 
predictive of failing early pregnancy. It has not, however, proved useful in 
determining the outcome of expectant management or in predicting the success of 
medical treatment and appears to add little to the diagnostic or prognostic value of 
two-dimensional imaging. 
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G.Acharya et al in 2002 used 3-D ultrasound volumetry of intrauterine 
contents in cases of normal and failed pregnancies and positively correlated these 
with the conventional 2-D measurements. Marc sutterlin et al gained insight into 
this comparison and found 3D to be superior to 2D volumetry. E Janniaux et al 
threw lights on predicting pregnancy outcome by using color Doppler which failed 
to demonstrate normal blood flow indices in pregnancies that subsequently ended 
in miscarriage. 
Babinszhi et al in June 2001 used 3-D measurement of yolk sac and 
gestational sac as predictors of pregnancy outcome in first trimester. Volumetry of 
G-sac proved to be a sensitive predictor of pregnancy outcome and a good 
supplement to CRL measurement. 
 
3.6. THE YOLK SAC 
 
The yolk sac appears as a circular transonic mass within the gestation sac 
and first be identified transvaginally at about 35 days, when it measures 3–4 mm in 
diameter . At this stage it is significantly larger than the embryo. It is a prominent 
landmark to search for within the early gestation sac and, because of its close 
association with the embryo at this stage, identifying it will automatically lead to 
the embryo.  
It is well known that the yolk sac is responsible for the execution of 
nutritional, endocrine, metabolic, immunologic, and hematopoietic functions 
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during organogenesis until establishment of the placental circulation. Because the 
yolk sac is of vital importance for embryologic development, a sonographic 
examination of an early pregnancy should include its assessment. Transvaginal 
sonography allows more detailed visualization of the yolk sac during early 
pregnancy. A sonographic examination should show the yolk sac before the 
diameter of the gestational sac becomes 8 mm in length. 
The yolk sac grows slowly until it reaches a maximum diameter of 6mm at 10 
weeks. The yolk sac floats freely in the chorionic cavity until the increasing size of 
the amniotic sac compresses it against the wall of the chorionic cavity. This factor 
makes identification of the yolk sac difficult after about 12weeks. Furthermore, in 
cases of missed abortion with a visible embryo, the yolk sac tends to be larger and 
its wall is thinner than in normal pregnancies 
. • Too large—more than 6 mm (over 2SD, sensitivity 16%, specificity 97%, 
PPV60%), 
• Too small—less than 3 mm (below 2SD, sensitivity 15%, specificity 95%, PPV 
44%), 
• Irregular shape—mainly wrinkled with indented walls, 
• Degenerative changes—abundant calcifications with decreased translucency of 
the yolk sac . 
• Number of yolk sacs—has to be equal to the number of the embryos 
 Currently, the major benefits of the sonographic evaluation of the yolk sac are: 
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1. Differentiation of potentially viable and nonviable gestations, 
2. Confirmation of the presence of an intrauterine pregnancy vs. a decidual cast, 
and 
3. Indication of a possible fetal abnormality. 
Yolk sac characteristics
  Normal yolk sac Abnormal yolk sac 
Size 
5–6 mm up to 9th week of 
gestation < 2 mm in 8 to 12 weeks (to small) 
    > 6 mm after 10th week (to large) 
Shape Round Oval, distorted 
Ultrasound 
finding 
Echoic rim, hypoechoic 
center Hyperechoic 
Doppler Absence of diastolic flow
Irregular blood flow Permanent diastolic 
flow Venous blood flow 
 
3.7. THE EMBRYO: 
Embryologically, the period from conception to the end of the ninth 
postmenstrual week is known as the ‘embryonic period’. The remaining 30 weeks 
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 Fig: 2, Ultrasound pictures illustrating the measurement of YSD in embryos 
with CRL of 8 mm (left) and 22 mm (right). The callipers are placed at the centre 
of the yolk sac wall. 
 
of pregnancy comprise the ‘fetal period’. The embryo can be visualized from about 
37days using the transvaginal route and is first seen as a bright linear echo, 
adjacent to the yolk sac and close to the connecting stalk. At this stage, the crown–
rump length (CRL) measures around 2 mm. Cardiac activity can be identified. 
When the embryo reaches 5 mm in length, equivalent to 6+3 weeks’ gestation and 
a mean sac diameter of 15–20 mm, it can be consistently seen separate from the 
yolk sac. The embryo grows at around 1 mm per day. 
 
3.8. EMBRYONIC HEART RATE 
All embryos of CRL >6 mm in length should demonstrate visible cardiac 
activity. Once an embryo with visible heart action is seen, the pregnancy is viable. 
Normal ranges for fetal heart rate in pregnancy have been described showing a 
rapid increase of the mean heart rate between 6 and 9 weeks followed by a slight 
decline after 10 weeks. It has been shown that a late onset of cardiac activity and a 
decreased heart rate in the first trimester are associated with a higher rate of 
spontaneous abortion. 
Lindsay and co-workers showed that the yolk sac in normal pregnancies and 
showed that a yolk sac diameter outside the 95% confidence limits was frequently 
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associated with a poor pregnancy outcome. G.Makrydimas et al on Sep 2003 
examined the value of ultrasound findings in the prediction of subsequent fetal loss 
and pregnancies with live fetuses at 6-10 weeeks gestation and found correlation 
with G-sac diameter and fetal heart rate. 
Online publication by T.Kucuk et al showed that yolk sac diameter of 2SD 
of the mean for the menstrual age allowed prediction of an abnormal pregnancy 
outcome. Cepni et al observed that when discrepancy is detected between 
secondary yolk sac diameter and gestational age it had an abnormal outcome.
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4.1. MATERIALS 
Period of study: December 2010 to November 2011 
Material: First trimester antenatal cases who were attendees of Govt. RSRM 
Lying-in Hospital attached to Stanley medical college, Chennai. 
Inclusion criteria: 
1. Antenatal patients with single gestation and live embryo 
2. Age < 30yrs 
Exclusion criteria: 
1. Pregnancy from infertility treatment 
2. Cases without embryonic heart rate, anembryonic pregnancy, subchorionic 
haemorrhage and inconsistency between gestational sac size and CRL. 
3. Women who has used any abortive or teratogenic drugs 
4.2. METHODS 
It is a prospective study conducted at government RSRM –lying in hospital 
attached to Stanley medical college, Chennai during A total of 120 antenatal 
women were included in the study belonging to first trimester. Women attending 
routine antenatal check up in the out-patient department were subjected to scan. 
Only those antenatal women who were <30 years and of singleton 
pregnancy were included in the study. The study included both primigravida and 
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multigravida. No socio-economic categorization was made. Patient with history of 
intake of teratogenic drugs, without embryonic heart rate, anembryonic pregnancy, 
subchorionic haemorrhage and inconsistency between gestational sac size and CRL 
were excluded from the study. 
A detailed history was elicited with special reference to the last menstrual 
period, its regularity and other associated risk factors like diabetes mellitus, 
hypertension, hypothyroidism, cardiac disease and bronchial asthma. Then a 
thorough general, physical, systematic and obstetric examination was carried out. 
After obtaining informed consent the women between 6-12 weeks of gestation 
were subjected to transvaginal ultrasound. 
4.2.1. MACHINE: 
All examination were performed using linear array real time B scan with 
 7.5 MHz transducer. 
4.2.2. MEASUREMENT OF GESTATIONAL SAC: 
After asking the patient to empty her bladder a small amount of gel is 
applied to transducer tip and covered by a condom.  A true saggital view of the 
uterus obtained and the transducer is gently panned side to side until the maximum 
depth of gestational sac is displayed. After freezing the image the maximum 
longitudinal diameter and the maximum anteroposterior diameter was measured. 
The transducer is rotated to 90 degree to obtain the cross section of sac and the 
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maximum transverse diameter is measured. By transvaginal approach abnormal 
gestational sac criteria include: 
• Impossibility to detect yolk sac when sac diameter is 8 mm or greater, or 
• Impossibility to detect cardiac activity when sac diameter is 16 mm or greater. 
When growth rate fails to increase at least 0.7 mm/day, abnormal sac and early 
embryo failure should be considered. 
Pseudogestational sac is characterized by either absent flow around it or very 
low velocity flow (<8 cm/s peak systolic velocity) and moderate resistance to 
blood flow (RI>0.50). Normal or abnormal intrauterine gestational sac is 
characterized by high velocity and low resistance pattern (RI<0.45). 
Measurement of the gestational sac volume by 3D US can be used for the 
estimation of gestational age in the early pregnancy. An abnormal measurement of 
gestational sac could potentially be used as a prognostic marker for pregnancy 
outcome. 
4.2.3. MEASUREMENT OF YOLK SAC: 
The yolk sac appears as a transonic mass within the gestational sac and it is 
measured by placing the caliper on the inner limits of longer diameter. Any yolk 
sac with totally smooth and no deformed margins was defined as having regular 
shape. The yolk sac with mainly wrinkled margins, indented walls was identified 
as having irregular shape. 
51 
 
4.2.4. MEASUREMENT OF EMBRYONIC HEART RATE: 
Heart rate – in the first trimester the measurement of heart rate should be 
performed using turnover M-mode. The heart rate increases rapidly from six to 
eight weeks and then remains relatively stable afterwards. 
4.2.5. MEASURE MENT OF CROWN RUMP LENGTH: 
A correctly performed measurement of CRL is the most accurate means of 
estimating the gestational age. An optimal CRL image, accurately measured, is  
more accurate  in dating a pregnancy. It is measured by obtaining a true, unflexed, 
longitudinal section of the embryo or fetus, with the end-points of the crown and 
rump clearly defined, and then placing the calipers correctly on these defined end-
points. Three measurements are taken and the average of them is taken as the 
crown rump length. 
 
 
 
 
 
 
52 
 
 
 
 
 
Results & 
Observation 
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5.0. RESULTS 
In our study 120 first trimester pregnant cases, who attended RSRM Lying 
in hospital, Royapuram were included as per criteria and data collected. The first 
trimester pregnancy outcome was evaluated by miscarriage or normal continuation 
of pregnancy.  
Age at the time of pregnancy and first Sonogram correlates with the first 
trimester pregnancy outcome (One way ANOVA p=0.028*). Mean age was 23.73 
years with minimum 16 years and maximum of 36 years. Regarding parity, primi 
to multipara women were included. In parity analysis Primi para were 84 cases. 
Among primi, 9 had miscarriage other 75 had normal pregnancy. As the number of 
previous abortions increases the chances of miscarriage also increases (Pearson 
Chi-square test p=0.043*). 
 
54 
 
Regarding marital status consanguinous marriage correlates with 
Miscarriage. Non consanguineous marriage was among 100 cases and third degree 
consanguineous marriage in 20 patients. In the normal outcome patients, non-
consanguinous marriage is in 89 cases (87.3%) and consanguinous marriage is in 
13 cases (12.7%). Among eighteen miscarriage cases 11 (61.1%) were non 
consanguinous marriage, 8 (38.9%) were consanguinous marriage. Consanguinity 
has highly significant correlation with pregnancy outcome (Pearson Chi-square 
test p=0.006**).  
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Number of years since married ranges between 0.3 and 7.0 years, with mean 
years of 2.06 and it has significant correlation with pregnancy outcome (T-test and 
p=0.025*). 
In our study 108 cases were without medical illnesses and about 12 cases 
with associated one of the medical illness. Medical illnesses were Systemic 
hypertension, polycystic ovary disease (PCOD), Diabetes Mellitus, Bronchial 
Asthma, Anemia and Hypothyroidism. Among cases without medical illness 93 
(86.1%) had normal pregnancy, 15 (13.9%) had miscarriage. Nine normal 
pregnancy outcomes with 3 miscarriages were in cases with Medical illness. 
Medical illness doesn’t has correlation with pregnancy outcome (Pearson Chi-
Square test p=0.306). 
Menstrual cycle was regular in 106 cases and 14 had irregular cycles. 
Among 102 normal pregnancy outcome patients 92 (90.2% of normal outcome) 
had regular menstrual cycle, 10 (9.8% of normal outcome) had irregular periods. 
Among eighteen miscarriage cases 14 (77.8% of miscarriage) had regular 
menstrual cycle, 4 (22.2% of miscarriage) had irregular menstrual cycle. Menstrual 
cycle does not correlate with pregnancy outcome in our study (Pearson Chi-Square 
test p=0.13). 
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The Gestational sac size ranges between 12 and 67 mm with a mean of 32.12 
mm. Among the normal pregnancy cases gestational sac size had a mean of 33.10 
mm in the first trimester. But in the miscarriage group Gestational sac had a mean 
of 26.61 mm. Gestational sac had highly significant correlation with the first 
trimester pregnancy outcome (T-test p=0.007**). 
The Yolk sac size varied between 2.5 to 7.0 with a mean of 4.892 mm. The 
Yolk sac size has significant correlation with the first trimester pregnancy 
outcome. (T-test p=0.002**). The heart rate of the fetus ranged between 100 and 
180, with a mean of 154.62. The heart rate of the fetus predicted the first trimester 
pregnancy outcome significantly (T-test p=0.048*).  
The gestational Age at the time of first scan predicted very significantly the 
first trimester pregnancy outcome (T-test p<0.001**) Gestational age ranged 
between 6.0 to 11.5 weeks with a mean of 8.426 weeks. The Crown Rump Length 
(CRL) was ranged between 10 and 58 mm with a mean of 24.51 mm. The CRL has 
significant predictive value in first trimester pregnancy outcome (T-test p=0.044*). 
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Table 1a: Descriptive data of all cases  (n=120): 
 
Data Minimum Maximum Mean 
Age (years) 16 36 23.73 
Married since (years) 0.3 7.0 2.062 
Gestational Sac Size (mm) 12 67 32.12 
Yolk sac size (mm) 2.5 7.0 4.892 
Heart Rate (Bpm) 100 180 154.62 
Gestational Age (weeks) 6.0 11.5 8.426 
Crown Rump Length (mm) 10 58 24.51 
 
 
Table 1b: Descriptive data of Miscarriage subset (n=18): 
 
  
Gestational 
Sac Size 
(mm) 
Yolk sac 
size (mm)
Heart Rate 
(Bpm) 
Gestational 
Age (weeks) 
Crown Rump 
Length (mm) 
Minimum 12 4.5 100 6.0 10 
Maximum 41 6.7 180 9.5 25 
Percentiles  25 21 4.7 123.00 6.0 20 
 50 25 5.25 159.50 7.0 22 
 75 32.75 6.0 162.75 8.5 23 
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Table 2: Marital status and Pregnancy outcome 
 
   
Pregnancy outcome 
Total Normal Miscarriage 
Marital status Non-
consanguinous 
Count 89 11 100 
% within Marital 
status 89.0% 11.0% 100.0% 
% within 
Pregnancy 
outcome 
87.3% 61.1% 83.3% 
Consanguinous Count 13 7 20 
% within Marital 
status 65.0% 35.0% 100.0% 
% within 
Pregnancy 
outcome 
12.7% 38.9% 16.7% 
Total Count 102 18 120 
% within Marital 
status 85.0% 15.0% 100.0% 
% within 
Pregnancy 
outcome 
100.0% 100.0% 100.0% 
 
 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig.  
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 7.529(b) 1 0.006**   
Continuity 
Correction(a) 5.765 1 0.016   
Likelihood Ratio 6.249 1 0.012   
Fisher's Exact Test    0.012 0.012 
Linear-by-Linear 
Association 7.467 1 0.006   
N of Valid Cases 120     
a  Computed only for a 2x2 table 
b  1 cells (25.0%) have expected count less than 5. The minimum expected count is 3.00. 
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Table 3: Menstrual cycle and Pregnancy outcome 
 
 
   
Pregnancy outcome 
Total Normal Miscarriage 
Menstrual cycle Regular Count 92 14 106 
% within 
Menstrual cycle 86.8% 13.2% 100.0% 
% within 
Pregnancy 
Outcome 
90.2% 77.8% 88.3% 
Irregular Count 10 4 14 
% within 
Menstrual cycle 71.4% 28.6% 100.0% 
% within 
Pregnancy cycle 9.8% 22.2% 11.7% 
Total Count 102 18 120 
% within 
Menstrual cycle 85.0% 15.0% 100.0% 
% within 
Pregnancy cycle 100.0% 100.0% 100.0% 
 
 
 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 2.290(b) 1 0.130   
Continuity Correction(a) 1.243 1 0.265   
Likelihood Ratio 1.952 1 0.162   
Fisher's Exact Test    0.223 0.134 
Linear-by-Linear 
Association 2.270 1 0.132   
N of Valid Cases 120      
a  Computed only for a 2x2 table 
b  1 cells (25.0%) have expected count less than 5. The minimum expected count is 2.10. 
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Table 4: Parity and Pregnancy outcome 
 
 
Parity 
 
  
  
  
Pregnancy Outcome 
Total 
  Normal Miscarriage 
 
Primi 
 
 
Count 75 9 84 
% within Parity 89.3% 10.7% 100.0% 
% within Pregnancy 
Outcome 73.5% 50.0% 70.0% 
 
 
G1P0A1L0 
 
 
Count 4 0 4 
% within Parity 100.0% 0% 100.0% 
% within Pregnancy 
Outcome 3.9% 0% 3.3% 
 
 
G2P1A0L1 
 
 
Count 11 2 13 
% within Parity 84.6% 15.4% 100.0% 
% within Pregnancy 
Outcome 10.8% 11.1% 10.8% 
 
 
G2P0L0A1 
 
 
Count 5 3 8 
% within Parity 62.5% 37.5% 100.0% 
% within Pregnancy 
Outcome 4.9% 16.7% 6.7% 
 
 
G2P1L0A1 
 
 
Count 1 2 3 
% within Parity 33.3% 66.7% 100.0% 
% within Pregnancy 
Outcome 1.0% 11.1% 2.5% 
 
 
G3P1L1A1 
 
 
Count 3 0 3 
% within Parity 100.0% 0% 100.0% 
% within Pregnancy 
Outcome 2.9% 0% 2.5% 
 
 
G3P0L0A2 
 
 
Count 1 1 2 
% within Parity 50.0% 50.0% 100.0% 
% within Pregnancy 
Outcome 1.0% 5.6% 1.7% 
 
 
G3P2L2A0 
 
 
Count 1 1 2 
% within Parity 50.0% 50.0% 100.0% 
% within Pregnancy 
Outcome 1.0% 5.6% 1.7% 
 
 
G4P1L1A2 
 
 
Count 1 0 1 
% within Parity 100.0% 0% 100.0% 
% within Pregnancy 
Outcome 1.0% 0% 0.8% 
Total 
 
 
Count 102 18 120 
% within Parity 85.0% 15.0% 100.0% 
% within Pregnancy 
Outcome 100.0% 100.0% 100.0% 
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Chi Square Test 
 
 Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 7.529(b) 1 0.006**   
Continuity Correction(a) 5.765 1 0.016   
Likelihood Ratio 6.249 1 0.012   
Fisher's Exact Test    0.012 0.012 
Linear-by-Linear 
Association 7.467 1 0.006   
N of Valid Cases 120     
a  Computed only for a 2x2 table 
b  1 cells (25.0%) have expected count less than 5. The minimum expected count is 3.00. 
 
 
Table 5: Medical Illness and Pregnancy outcome 
  
Pregnancy outcome 
Total Normal Miscarriage 
Medical Illness No Count 93 15 108 
  % within Medical 
Illness 86.1% 13.9% 100.0% 
  % within Follow up 91.2% 83.3% 90.0% 
  Yes Count 9 3 12 
  % within Medical 
Illness 75.0% 25.0% 100.0% 
  % within Follow up 8.8% 16.7% 10.0% 
Total 
  
  
 Count 102 18 120 
% within Medical 
Illness 85.0% 15.0% 100.0% 
% within Follow up 100.0% 100.0% 100.0% 
 
Chi-Square Tests 
 
  Value 
Asymp. Sig.  
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig. 
 (1-sided) 
Pearson Chi-Square 1.046(b) 0.306   
Continuity Correction(a) 0.356 0.551   
Likelihood Ratio 0.919 0.338   
Fisher's Exact Test   0.387 0.259 
Linear-by-Linear Association 
1.037 0.309   
N of Valid Cases 120    
a  Computed only for a 2x2 table 
b  1 cells (25.0%) have expected count less than 5. The minimum expected count is 1.80. 
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Table 6: Age and Pregnancy outcome: 
T-Test Group Statistics 
 
  Pregnancy outcome N Mean Std. Deviation 
Std. Error 
Mean 
Age in years Normal 102 23.41 3.697 0.366 
  Miscarriage 18 25.50 3.451 0.813 
 
 
Independent Samples Test 
 
  
  
  
t-test for Equality of Means 
t 
 
df 
 
Sig. (2-tailed) 
 
Mean 
Difference 
 
95% Confidence Interval of the 
Difference 
Lower Upper 
Age in years -2.230 118 0.028* -2.09 -3.943 -0.234 
  -2.341 24.415 0.028 -2.09 -3.928 -0.249 
 
 
 
 
Table 7: Number of years since married and Pregnancy outcome: 
 
T-Test Group Statistics 
 
 Pregnancy outcome N Mean Std. Deviation Std. Error Mean 
No. of years married Normal 102 1.911 1.7105 0.1694 
Miscarriage 18 2.917 1.8570 0.4377 
 
 
Independent Samples Test 
 
  
  
  
t-test for Equality of Means 
t 
 
df 
 
Sig. 
(2-tailed) 
 
Mean 
Difference 
 
95% Confidence Interval of the 
Difference 
Lower Upper 
No. of years 
married -2.271 118 0.025* -1.006 -1.8829 -.1288 
  
-2.143 22.387 0.043 -1.006 -1.9782 -.0335 
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Table 8: Yolk sac Size and Pregnancy outcome: 
 
T-Test Group Statistics 
 
 
Pregnancy 
outcome N Mean Std. Deviation 
Std. Error 
Mean 
Yolk sac (mm) Normal 102 4.804 0.7304 0.0723 
Miscarriage 18 5.389 0.6764 0.1594 
 
 
  
Independent Samples Test 
 
  
  
  
t-test for Equality of Means 
t 
 
df 
 
Sig. (2-tailed) 
 
Mean 
Difference 
 
95% Confidence Interval of the 
Difference 
Lower Upper 
Yolk sac (mm) 
-3.165 118 0.002** -0.585 -0.9509 -0.2190 
  
-3.341 24.541 0.003 -0.585 -0.9459 -0.2241 
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Area Under the Curve 
Test Result Variable(s):Yolk sac (mm)   
Area Std. Errora Asymptotic Sig.b 
Asymptotic 95% Confidence Interval 
Lower Bound Upper Bound 
0.710 0.070 0.005* 0.573 0.847 
The test result variable(s): Yolk sac (mm) has at least one tie between the positive actual state 
group and the negative actual state group. Statistics may be biased. 
a. Under the nonparametric assumption  
b. Null hypothesis: true area = 0.5   
 
 
 
 
 
Table 9: Embryonic heart rate and pregnancy outcome: 
 
T-Test Group Statistics 
 
  Pregnancy outcome N Mean Std. Deviation 
Std. Error 
Mean 
Embryonic Heart 
Rate (bpm) 
Normal 102 155.88 14.298 1.416 
  Miscarriage 18 147.44 26.203 6.176 
 
 
Independent Samples Test 
 
  
  
  
t-test for Equality of Means 
t 
 
df 
 
Sig. (2-
tailed) 
 
Mean 
Difference 
 
95% Confidence Interval of the Difference
Lower Upper 
Embryonic 
Heart Rate 
(bpm) 
1.994 118 0.048* 8.44 0.059 16.817 
  
1.332 18.825 0.199 8.44 -4.833 21.708 
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Table 10: Gestational Age and Pregnancy Outcome: 
 
T-Test Group Statistics 
 
  
Pregnancy 
Outcome N Mean Std. Deviation 
Std. Error 
Mean 
Gestational Age 
(weeks) 
Normal 102 8.638 1.1649 0.1153 
Miscarriage 18 7.222 1.1909 0.2807 
 
 
Independent Samples Test 
 
 
t-test for Equality of Means 
t 
 
df 
 
Sig. (2-tailed) 
 
Mean 
Difference 
 
95% Confidence Interval of the 
Difference 
Lower Upper 
Gestational 
Age (weeks) 4.739 118 0.000** 1.416 .8243 2.0077 
 
4.666 23.115 0.000 1.416 .7884 2.0436 
 
 
 
Table 11: Crown Rump Length and Pregnancy Outcome: 
 
T-Test Group Statistics 
 
  
Pregnancy 
Outcome N Mean Std. Deviation Std. Error Mean 
Crown Rump 
Length (mm) 
Normal 102 25.21 9.508 0.941 
     
Miscarriage 18 20.56 4.176 0.984 
 
 
Independent Samples Test 
 
  
  
  
t-test for Equality of Means 
t 
  
df 
  
Sig. (2-tailed) 
  
Mean 
Difference 
  
95% Confidence Interval of the 
Difference 
Lower Upper 
Crown Rump 
Length (mm) 2.035 118 0.044* 4.65 0.125 9.175 
  
3.414 54.637 0.001 4.65 1.920 7.380 
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Table 12: Gestational Sac Size and Pregnancy Outcome 
 
T-Test Group Statistics 
 
 
Pregnancy 
Outcome N Mean Std. Deviation 
Std. Error 
Mean 
Gestational Sac 
size (mm) 
Normal 102 33.10 9.330 0.924 
Miscarriage 18 26.61 8.465 1.995 
 
 
Independent Samples Test 
 
  
  
  
t-test for Equality of Means 
t 
 
df 
 
Sig. (2-tailed) 
 
Mean Difference 
 
95% Confidence Interval of the 
Difference 
Lower Upper 
SAC size (cms) 
2.755 118 0.007** 6.49 1.824 11.150 
  
2.950 24.876 0.007 6.49 1.957 11.017 
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Table 13a: Correlation of Pregnancy outcome with all other parameters 
(AFTER EXCLUDING THE CASES WITH UNKNOWN ‘LMP’) (n=108) 
One Way ANOVA with Post HOC Turkey test 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
AGE Between Groups 46.357 1 46.357 3.752 0.055*
Within Groups 1309.523 106 12.354   
Total 1355.880 107    
PARITY Between Groups 13.683 1 13.683 4.212 0.043*
Within Groups 344.317 106 3.248   
Total 358.000 107    
Marital Status Between Groups .846 1 0.846 7.016 0.009**
Within Groups 12.783 106 0.121   
Total 13.630 107    
Marital years Between Groups 10.882 1 10.882 3.447 0.066*
Within Groups 334.641 106 3.157   
Total 345.523 107    
Menstrual cycle Between Groups .252 1 0.252 4.236 0.042*
Within Groups 6.295 106 0.059   
Total 6.546 107    
Weeks at which 
first scan taken 
Between Groups 2.332 1 2.332 1.295 0.258
Within Groups 187.209 104 1.800   
Total 189.540 105    
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Table 13b: Correlation of Pregnancy outcome with all other parameters 
(AFTER EXCLUDING THE CASES WITH UNKNOWN ‘LMP’) (n=108) 
One Way ANOVA with Post HOC Turkey test 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
Gestational 
Sac Size 
Between Groups 515.222 1 515.222 6.792 0.010* 
Within Groups 8040.518 106 75.854   
Total 8555.741 107    
Yolk sac size Between Groups 7.507 1 7.507 16.886 0.000** 
Within Groups 47.123 106 .445   
Total 54.629 107    
Embryonic 
heart rate 
Between Groups 1069.914 1 1069.914 3.763 0.055* 
Within Groups 30140.271 106 284.342   
Total 31210.185 107    
Gestational 
age 
Between Groups 23.553 1 23.553 18.119 0.000** 
Within Groups 137.791 106 1.300   
Total 161.343 107    
CRL Between Groups 196.721 1 196.721 3.257 0.074 
Within Groups 6401.529 106 60.392   
Total 6598.250 107    
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6.0. DISCUSSION 
 Miscarriage occurs in approximately 30–40% of implanted pregnancies, is 
the commonest complication of pregnancy [4]. Numerous studies have examined 
the potential value of demographic characteristics and various ultrasonographic 
parameters in the prediction of those pregnancies that will miscarry. These studies 
have reported an association between increased risk for miscarriage and advanced 
maternal age, previous history of miscarriage, vaginal bleeding, fetal bradycardia, 
early onset fetal growth restriction, small gestational sac volume and large yolk 
sac. However, most of these studies included small numbers of patients, were 
retrospective or were carried out in highly selected populations, including women 
presenting with vaginal bleeding or abdominal pain and in pregnancies achieved 
using assisted reproduction techniques [5]. In the light of these limitations, we did 
a prospective study in this topic. 
In our prospective study 120 antenatal women were included belonging to 
first trimester, who were attendees of Govt. RSRM Lying-in Hospital attached to 
Stanley medical college, during December 2010 to November 2011. There was a 
linear correlation (p=0.028*) between the age at time of pregnancy and 
miscarriage. Our study supports the fact that as the maternal age increases, chances 
of spontaneous abortion also increases. Studies have also shown that the rate of 
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spontaneous abortion following cardiac activity is influenced by maternal age. So a 
cardiac activity is not necessarily a reassuring sign in the older patient [6].  
Our study is in agreement with the fact that consanguinous marriage 
increases the adverse outcome. Consanguinous marriage is still prevalent in the 
population studied. Chama et al recommended that patients at risk of prior 
pregnancy outcome should have routine TVS before 12 weeks of pregnancy to 
assess the yolk sac and those with abnormal yolk sac should be followed to 
exclude fetal abnormalities before 24 weeks of gestation. Menstrual cycle 
irregularity was noted in 14 cases among them only 4 cases aborted, and menstrual 
cycle irregularity doesn’t correlate with the first trimester outcome as such. But, 
after excluding the cases with unknown LMP, menstrual cycle correlates 
significantly (p=0.042*) with pregnancy outcome [Table 13a]. 
 Previous abortions have significantly influenced the present pregnancy 
(p=0.006**). Among 20 cases with previous abortions, 6 of them aborted in the 
present pregnancy. According to Soyoung Bae et al, for women with a history of 
recurrent pregnancy loss, if embryonic cardiac activity, yolk sac and gestational 
sac markers were present, the rate of accurate positive (normal continuation) 
prediction was 94%. But any change in these parameters may affect current 
pregnancy as per our study. Makrydimas et al seem to agree with the negative 
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impact of advanced maternal age and history of miscarriages to subsequent 
pregnancy outcome [5].    
In our study medical illness in the mother does not correlate with the 
pregnancy outcome (p=0.306). This is accordance with the previous studies. So the 
women with previous medical illness like systemic hypertension, PCOD, Diabetes 
Mellitus, Hypothyroidism may have good outcome of first trimester provided the 
fetal cardiac rate and Yolk sac size are within normal range. 
In our study Gestational sac mean size was 32.12 and significantly correlates 
with the first trimester outcome (p=0.007**). It was 33.10 mm mean in the normal 
pregnancies and mean of 26.61mm in miscarriage group. It has long been 
recognized that there is wide scatter in gestational sac volume measurements in 
‘normal’ early pregnancy [7]. A smaller than expected gestational sac can be a 
predictor of poor pregnancy outcome, both alone and in combination with other 
parameters, even in the presence of embryonic cardiac activity, In very early 
pregnancy, there appears to be no difference in gestational sac diameter (GSD) 
when compared with pregnancy outcome, the difference only becoming apparent 
from 5 weeks onwards [8]. Once a gestational sac has been documented on 
ultrasound, subsequent loss of viability in the embryonic period remains around 
11% [9]. So, Gestational sac size measurements could not be considered as good 
79 
 
predictor of first trimester outcome even though it had significant correlation in our 
study. 
 The increase in yolk sac diameter during the first trimester and its 
correlation with advancing gestational age lie in agreement with most of the 
previous studies [10], although some researchers support that the growth of yolk 
sac during the first trimester is not constant [11]. We demonstrated that the 
pregnancies with mean yolk sac diameter>or=5 mm on early ultrasound require 
monitoring and counseling. About a threefold increased risk for first-trimester loss 
independent of maternal risk factors such as age, body mass index, polycystic 
ovary syndrome, smoking, and diabetes and we agree with recent studies that 
support the negative predictive value of the absence of yolk sac [12] [13]. We 
studied only the yolk sac size and not its shape; therefore we cannot comment on 
previous articles that associate abnormal shapes of the yolk sac with poor 
pregnancy outcome [14]. In addition, enlarged yolk sac diameter may be associated 
with an increased risk of preterm delivery [15]. 
 Embryonic heart rate has significant correlation with the first trimester 
outcome in our study (p=0.048*). FHR has been studied extensively and numerous 
studies have demonstrated a strong association between pathological FHR and fetal 
loss. Fetal bradycardia is a sign of impending fetal death reflecting the forthcoming 
collapse of the cardiovascular system. Another possible cause for the high 
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miscarriage rate in fetuses with abnormal FHR is that there may be an underlying 
chromosomal abnormality, such as trisomy 18 or triploidy, which is associated 
with fetal bradycardia [16]. But tachycardia is a feature of trisomy 21(Down 
Syndrome [17]. 
 The ultrasonographic estimation of gestational age in our study has 
significant correlation with pregnancy outcome (p<0.001**). The inverse 
relationship between gestational age and fetal loss rate is consistent with the results 
of previous studies and may also be a consequence of the high early lethality of 
chromosomally abnormal embryos [18]. For example, a previous study of 6337 
pregnancies reported an inverse correlation between gestation and rate of 
subsequent fetal loss, which decreased by about 1% per week from 9.6% at 7 
weeks to 2.3 at 14 weeks [19].   
 In fetuses with CRL < 18 mm there was a significant positive association 
between the deficit in CRL for gestation and the incidence of subsequent 
spontaneous miscarriage [20]. In our study Crown rump length inversely 
associated with miscarriage (p=0.044*). CRL is <22mm in miscarriages in our 
study, this correlation stands with most of the previous studies. The measurement 
of fetal CRL may be a useful predictor of spontaneous miscarriage and SGA in 
pregnancies with threatened miscarriage.  
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 The routine use of TVS in the investigation and diagnosis of early pregnancy 
problems has also led to improvements in the management of early pregnancy loss. 
Improved access to early pregnancy units and increasing awareness amongst 
women of their choices in the management of early pregnancy problems has led to 
an increasing demand for more conservative management of early miscarriage. Up 
to 70% of women will choose expectant management of miscarriage if given the 
choice [21]. For these purposes the predictors of early fetal demise and monitoring 
the same is essential in the current practice.We did follow up scans for the patients 
who had abnormal ultrasonic markers. Twenty two cases have undergone follow 
up scan, among them only 6 had normal continuation of pregnancy, remaining 16 
aborted (p<0.001**).   
 The limitation of ultrasound examination depends on the machine type, 
operator factors and timing of scan and our study also has limitation of low 
volume. In spite of all these limitations we postulate that measurement of yolk sac 
size and embryonic heart rate in early pregnancy may predict the first trimester 
outcome and plan for timing of follow up; also to counsel the patient about the 
short term and long term outcomes. 
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 7.1 SUMMARY  
      In our prospective study of 120 patients there was a linear correlation between 
age at the time of pregnancy and miscarriage. As the maternal age increases, there 
is increased chance of spontaneous abortion. 
      Consanguinous marriage influences the pregnancy outcome. There is increased 
rate of abortion among consanguinous marriage compared to non-consanguinity. 
In our study women with medical illness like systemic hypertension, diabetes 
mellitus, hypothyroidism also had a good outcome. Medical illness in the mother 
does not correlate with pregnancy outcome. 
      Patients with history of previous abortions are likely to have subsequent 
abortion in the following pregnancy. 
      Gestational sac size significantly correlates with the first trimester pregnancy 
outcome. A smaller than expected gestational sac can be a predictor of poor 
pregnancy outcome both alone or in combination with other parameters. 
      Yolk sac diameter in the first trimester significantly correlates with the 
pregnancy outcome. An enlarged yolk sac has increased risk of preterm delivery. 
      In our study embryonic heart rate influences the pregnancy outcome. Fetal 
bradycardia is a sign of impending fetal death mostly due to chromosomal 
abnormality trisomy 18 and triploidy. Tachycardia is a feature of trisomy 21. 
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7.2 CONCLUSION 
The conclusion drawn from the present study are as follows 
1. Maternal age correlates with the pregnancy outcome. As the maternal age 
increases the chances of miscarriage increases. 
2.  Miscarriages are more common among the patients with consanguinous 
marriage. 
3.  The pregnancy outcome is not influenced by the medical illness in the 
mother. 
4.  The gestational sac size significantly correlates with the first trimester 
pregnancy outcome. 
5.  Yolk sac diameter and embryonic heart rate in the first trimester 
significantly correlates with the first trimester pregnancy outcome. 
Thus the present study indicates that the yolk sac size and the embryonic 
heart rate is a reliable, cost effective and beneficial in predicting first trimester 
pregnancy outcome especially in patients who conceive following IVF.  
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PROFORMA 
YOLK SAC MEASUREMENTS AND EMBRYONIC HEART RATE IN 
PREDICTING FIRST TRIMESTER PREGNANCY OUTCOME. 
NAME            :                                AGE:              I.P. NO.  : 
SOCIAL STATUS  :                           BOOKED/UNBOOKED: 
LMP   :                                              G    P    L    A 
EDD   :                                               GESTATIONAL AGE   : 
DATE OF USG   : 
OBSTETRIC HISTORY   : 
MATERNAL ILLNESS   : 
GENERAL EXAMINATION   : 
HT.                WT.                  PULSE:                BP:            TEMP: 
ANAEMIA:                           EDEMA:               CVS:           RS: 
OBETETRIC EXAMINATION 
P/A                : 
 
USG                
GESTATIONAL SAC   SIZE:                    EMBRYONIC HEART RATE: 
YOLK SAC SIZE                   :                   GESTATIONAL AGE: 
92 
 
KEY TO MASTER CHART  
P‐parity                                                 LMP‐last menstrual period 
1 –primi                                           GS   ‐gestational sac 
2 –G2A1                                           YS  ‐  yolk sac 
3 –G2P1L1                                        HR  ‐heart rate 
4 –G3P1L0A1                                   GA  ‐ gestational age 
5 –G2P1L0A1                                   CRL‐ crown rump length 
6 –G3P1L1A1                                   
7 –G3A2                                            FU  ‐follow up 
8 –G3P2L2                                         0    ‐normal 
9 –G4P1L1A2                                    1    ‐miscarriage 
MS‐ marital status 
0 ‐non‐consanguinous marriage 
1 –consanguinous marriage 
MC‐ menstrual cycle 
0 ‐regular 
1 –irregular 
MI‐medical illness 
0 ‐no 
1 ‐yes 
 
